This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/525540-india-vaccine-covid-order/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| India pre-orders 300 million doses of unapproved Covid-19 vaccine by domestic drugmaker Biological-E | India pre-orders 300 million doses of unapproved Covid-19 vaccine by domestic drugmaker Biological-E |
| (3 months later) | |
| The Indian government has paid some $205 million in advance for 300 million doses of a new coronavirus vaccine by domestic firm Biological-E. The shot has not been approved yet and is still undergoing clinical trials. | The Indian government has paid some $205 million in advance for 300 million doses of a new coronavirus vaccine by domestic firm Biological-E. The shot has not been approved yet and is still undergoing clinical trials. |
| The advance agreement was announced by India’s health ministry on Thursday, and is the first deal inked by New Delhi to procure a vaccine in the early stage of development. | The advance agreement was announced by India’s health ministry on Thursday, and is the first deal inked by New Delhi to procure a vaccine in the early stage of development. |
| Little is known about the shot by Biological-E, which is one of the oldest vaccine-making companies in the country. The jab is said to be undergoing phase-3 clinical trials and is expected to be “manufactured and procured between August-December” this year. | Little is known about the shot by Biological-E, which is one of the oldest vaccine-making companies in the country. The jab is said to be undergoing phase-3 clinical trials and is expected to be “manufactured and procured between August-December” this year. |
| Apart from developing its own vaccine, Biological-E also has a deal to produce around 600 million Johnson &Johnson Covid-19 shots annually. Earlier this week, the company also said it had reached a licensing agreement with Canada-based Providence Therapeutics Holdings to manufacture its vaccine, the PTX-COVID19-B. The vaccine, based on messenger RNA technology, remains in the very early stages of development. Biological-E will conduct clinical trials for Providence's jab in India, and seek approval for its emergency use. | Apart from developing its own vaccine, Biological-E also has a deal to produce around 600 million Johnson &Johnson Covid-19 shots annually. Earlier this week, the company also said it had reached a licensing agreement with Canada-based Providence Therapeutics Holdings to manufacture its vaccine, the PTX-COVID19-B. The vaccine, based on messenger RNA technology, remains in the very early stages of development. Biological-E will conduct clinical trials for Providence's jab in India, and seek approval for its emergency use. |
| India has been struggling with a devastating second wave of coronavirus, which hit the country hard over the past few weeks.While the situation has recently improved, India still registers over 100,000 new cases daily, with its all-time tally currently hovering just below 28.5 million. Nearly 338,000 people have succumbed to the disease in the country since the beginning of the pandemic. | India has been struggling with a devastating second wave of coronavirus, which hit the country hard over the past few weeks.While the situation has recently improved, India still registers over 100,000 new cases daily, with its all-time tally currently hovering just below 28.5 million. Nearly 338,000 people have succumbed to the disease in the country since the beginning of the pandemic. |
| While the Indian government has launched a massive inoculation campaign, so far only around 3% of the country’s massive 1.36 billion population have been fully vaccinated. In total, more than 221 million doses of various coronavirus vaccines have been distributed among India’s population. | While the Indian government has launched a massive inoculation campaign, so far only around 3% of the country’s massive 1.36 billion population have been fully vaccinated. In total, more than 221 million doses of various coronavirus vaccines have been distributed among India’s population. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |